维普中文期刊产品整合服务
4篇 您的检索式:作者名="Susan Win"
    题名 作者 年代 出处 被引量
1Rising incidence of early‐onset colorectal cancer in A ustralia over two decades: Report and review显示文摘Joanne P Young Aung Ko Win Christophe Rosty Ingrid Flight David Roder Graeme P Young Oliver Frank Graeme K Suthers Peter J Hewett Andrew Ruszkiewicz Ehud Hauben Barbara‐Ann Adelstein Susan Parry Amanda Townsend Jennifer E Hardingham Timothy J Price 2015J Gastroenterol Hepatol2015,,:1
2Risk of Metachronous Colon Cancer Following Surgery for Rectal Cancer in Mismatch Repair Gene Mutation Carriers显示文摘Aung Ko Win Susan Parry Bryan Parry Matthew F. Kalady Finlay A. Macrae Dennis J. Ahnen Graeme P. Young Lara Lipton Ingrid Winship Alex Boussioutas Joanne P. Young Daniel D. Buchanan Julie Arnold Lo?c Le Marchand Polly A. Newcomb Robert W. Haile Noralane M 2013Annals of Surgical Oncology2013,,6:1
3QUASI-CONCAVE MULTIPLE OBJECTIVE PROGRAMMING WITH CONE STRUCTURE显示文摘QUASI-CONCAVEMULTIPLEOBJECTIVEPROGRAMMINGWITHCONESTRUCTURE¥HUANGZhimin;LISusanX.(SchoolsofBusinessandBanking,AdelphiUniversit...HUANG Zhimin LI Susan X.(Schools of Business and Banking, Adelphi University, Garden City,New York 11530.USA)Win Quang(The Institute of Operations Research and Mathematical economics,the People’s University of China, Beijing 100872,China) 1996Systems Science and Mathematical Sciences1996,9,1:0
4Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn’s disease显示文摘BACKGROUND Evidence suggests inflammatory mesenteric fat is involved in post-operative recurrence(POR)of Crohn’s disease(CD).However,its prognostic value is INTRODUCTION Crohn’s disease(CD)is a debilitating chronic immune-mediated inflammatory disease(IMID)of the gastrointestinal tract that is increasing in incidence and prevalence globally[1].CD patients often undergo surgery for disease-related complic-ations and/or medically refractory disease.Unfortunately,surgery is not curative,and many patients develop post-operative recurrence(POR)of CD with a significant proportion eventually requiring additional surgeries.With advances in early detection and therapeutics,the contemporary 10-year risk of surgery has improved from 50%to 26%,but the risk of recurrent surgery has remained unchanged at 30%,suggesting a need to improve post-operative management strategies[2].Presently,there are two accepted strategies to mitigate POR,but each have potential limitations.Firstly,patients start early post-operative pharmacologic prophylaxis within 4-6 wk after surgery.This strategy can potentially overtreat a subset of patient who may not develop long-term disease recurrence off therapy.Consequently,these patients are at risk of medication-related adverse events and the direct and indirect costs associated with therapy with little or no benefit[3].The second strategy is performing early colonoscopy within 6-12 months after surgery and escalating therapy based on FOOTNOTES Author contributions:Gu P is the guarantor of the article and was involved in concept and design,data collection,statistical analysis,drafting of manuscript,and final approval of manuscript;Dube S and Choi SY were involved in statistical analysis,drafting of the manuscript,and final approval of manuscript;Gellada N,Win S,Lee YJ and Yang S were involved in the data collection,drafting of the manuscript,and final approval of manuscript;Haritunians T and Li D were involved in data analysis and interpretation,drafting of manuscript and final approval of manuscript;Melmed GY,Yarur AJ,Fleshner P,Kallman C and Devkota S were involved in study concept and design,data interpretation,drafting of manuscript and final approval of manuscript;Vasiliauskas EA,Bonthala N,Syal G,Ziring D and Targan SR were involved in data interpretation,drafting of manuscript and final approval of manuscript;Rabizadeh S was involved in study concept and design,drafting of manuscript and final approval of manuscript;McGovern DPB was involved in concept and design,statistical analysis,drafting of manuscript and final approval of manuscript.Phillip Gu Shishir Dube Norman Gellada So Yung Choi Susan Win Yoo Jin Lee Shaohong Yang Talin Haritunians Gil Y Melmed Eric A Vasiliauskas Niru Bonthala Gaurav Syal Andres J Yarur David Ziring Shervin Rabizadeh Phillip Fleshner Cindy Kallman Suzanne Devkota Stephan R Targan Dalin Li Dermot PB McGovern 2024World Journal of Gastrointestinal Surgery2024,16,3:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费